Are you Dr. Knoblauch?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 47 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
1 Maloney Building
Philadelphia, PA 19104Phone+1 215-662-3957
Summary
- Dr. Roland Knoblauch, MD is an oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2004 - 2007
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2001 - 2004
New York University School of MedicineClass of 2001
Certifications & Licensure
PA State Medical License 2004 - 2024
Publications & Presentations
PubMed
- 3 citationsDetermination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non-Small Cell Lung Cancer.Nahor Haddish-Berhane, Yaming Su, Alberto Russu, Meena Thayu, Roland E Knoblauch
Clinical Pharmacology and Therapeutics. 2024-03-01 - 27 citationsAmivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial.Byoung Chul Cho, Dong-Wan Kim, Alexander I Spira, Jorge E Gomez, Eric B Haura
Nature Medicine. 2023-10-01 - 6 citationsManagement of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study.Keunchil Park, Joshua K Sabari, Eric B Haura, Catherine A Shu, Alexander Spira
Lung Cancer. 2023-04-01
Press Mentions
FDA Approves Yondelis for Two Common Subtypes of Soft Tissue SarcomaOctober 26th, 2015
